Search results
AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
Zacks via Yahoo Finance Canada· 5 days agoAbbVie's (ABBV) acquisition of Celsius Therapeutics is set to add the latter's lead pipeline...
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
Zacks via Yahoo Finance Canada· 6 days agoShares of this drugmaker have returned +10.6% over the past month versus the Zacks S&P 500 composite's +3.4% change. The Zacks Large Cap Pharmaceuticals...
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Zacks via Yahoo Finance Canada· 5 days agopharmaceutical companies. It is designed to provide capital appreciation by thoroughly evaluating...
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Zacks via Yahoo Finance Canada· 5 days agoCap Pharmaceuticals Industry 5YR % Return Large Cap Pharmaceuticals Industry 5YR % Return Here’s how...
MedinCell And Two More Euronext Paris Growth Stocks With High Insider Ownership
Simply Wall St. via Yahoo Finance Canada· 5 hours agoAs the French market navigates through a period of political uncertainty with upcoming elections,...
Novo Nordisk, Lilly must cut US prices of weight-loss drugs, Biden says
Reuters via Yahoo Canada News· 22 hours ago(Reuters) -U.S. President Joe Biden and Senator Bernie Sanders called on Novo Nordisk and Eli Lilly...
Top Insider-Owned Growth Companies On Euronext Paris July 2024
Simply Wall St. via Yahoo Finance Canada· 1 day agoAmid a backdrop of heightened political uncertainty and fluctuating market indices, France's...
3 Healthcare Mutual Funds Thriving Amid Economic Shifts
Zacks via Yahoo Finance Canada· 7 days agoHealthcare mutual funds such as FPHAX, VGHCX and PHSTX are increasingly favored as solid investments...
The Corporate Reputation of Canadian Pharma, 2023-2024 - 100 Patient Groups Present their Views -...
Financial Post· 6 days agoDUBLIN — “The Corporate Reputation of Pharma in 2023/2024 – The Patient Perspective – Canada Edition – The Views of 100 Canadian Patient Groups” report has been added to ResearchAndMarkets.com ...
Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
Zacks via Yahoo Finance Canada· 6 days agoThe FDA's CRL to Merck (MRK) and its partner Daiichi Sankyo for the patritumab deruxtecan BLA is...
